Advertisement

Infectious Disease

Home Infectious Disease
Up to 75

Deaths of Despair Likely to Increase During Pandemic

Authors propose policies addressing employment; access to care; and integrated behavioral, clinical care
Angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker use is not associated with COVID-19 test positivity

ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity

No significant association identified in overlap propensity score weighting analysis
Among prostate cancer patients

Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT

Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
Severe acute respiratory syndrome coronavirus 2 is present in the semen of some patients with COVID-19

SARS-CoV-2 Identified in Semen of Men With COVID-19

SARS-CoV-2 present in 26.7 percent at acute stage of infection, 8.7 percent of recovering patients
Medication adherence for asthma and chronic obstructive pulmonary disease has increased during the COVID-19 pandemic

Asthma, COPD Medication Adherence Up During Pandemic

Authors say increased adherence may reflect patient concern about controlling primary respiratory illness
The overall infection fatality rate among symptomatic COVID-19 cases in the United States is estimated at 1.3 percent

Symptomatic COVID-19 Infection Fatality Rate 1.3 Percent in U.S.

County-specific infection fatality rates for symptomatic cases varied from 0.5 to 3.6 percent
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 4 to 8

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
The New York State Department of Health issued an advisory on May 6 regarding cases of pediatric multisystem inflammatory syndrome potentially associated with COVID-19.

New York State Reports Cases of Pediatric Inflammatory Syndrome Tied to COVID-19

Pediatric patients presenting with compatible symptoms should undergo SARS-CoV-2 testing
A novel rifabutin-based triple therapy is effective for eradication of Helicobacter pylori

RHB-105 Effective for Eradication of Helicobacter pylori in Adults

Eradication rates with triple therapy unaffected by resistance to clarithromycin, metronidazole
For patients hospitalized with COVID-19

Anticoagulation May Improve Outcomes in COVID-19 Patients

Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients